Scrip's Five Must-Know Things - Aug. 17, 2026

Audio roundup of selected biopharma industry content from Scrip over the business week ended Aug. 14, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.

This time—a look at the global IPF pipeline; US approval for Takeda's narcolepsy drug; Arrowhead talks differentiation in severe hypertriglyceridemia; SMID Q2 developments; and Attruby positioning in transthyretin-mediated amyloidosis with cardiomyopathy.

Story links: insights.citeline.com/scrip/podcasts/scrips-fi…

This and all our other podcasts are available on the new Scrip channel on Apple Podcasts (podcasts.apple.com/us/podcast/scrip-podcasts/i…), and Spotify Podcasts (open.spotify.com/show/54Ki1l5bTzuxvrUylwbvO9?s…)and on TuneIn (tunein.com/podcasts/Business--Economics-Podcas…).

Contact us on podcasts@norstella.com.